Stem cell-based therapies for type 1 diabetes:Progress in differentiation,clinical translation,and immune protectionOA
Stem cell-based therapies for type 1 diabetes:Progress in differentiation,clinical translation,and immune protection
Zifan Li;Yu Kang;Yuyu Niu
State Key Laboratory of Primate Biomedical Research||Institute of Primate Translational Medicine,Kunming University of Science and Technology,Kunming,Yunnan,China||Yunnan Key Laboratory of Primate Biomedical Research,Kunming,Yunnan,ChinaState Key Laboratory of Primate Biomedical Research||Institute of Primate Translational Medicine,Kunming University of Science and Technology,Kunming,Yunnan,China||Yunnan Key Laboratory of Primate Biomedical Research,Kunming,Yunnan,ChinaState Key Laboratory of Primate Biomedical Research||Institute of Primate Translational Medicine,Kunming University of Science and Technology,Kunming,Yunnan,China||Yunnan Key Laboratory of Primate Biomedical Research,Kunming,Yunnan,China||Southwest United Graduate School,Kunming,Yunnan,China
immune rejectionislet organoidsstem cell therapytype 1 diabetesβ cells
immune rejectionislet organoidsstem cell therapytype 1 diabetesβ cells
《动物模型与实验医学（英文）》 2026 (7)
1277-1291,15
National Key R&D Program of China,Grant/Award Number:2021YFA0805700 and 2021YFA1102000National Natural Science Foundation of China,Grant/Award Number:U2102204Natural Science Foundation of Yunnan Province,Grant/Award Number:202102AA100053 and 202403AH310053Xingdian Talent Support Plan of Yunnan Province,China,Grant/Award Number:202405AB350001
评论